Clinical Trial Record

Return to Clinical Trials

Effects of Prehabilitation and Early Mobilization for Patients Undergoing Pancreas Surgery.


2017-12-18


2020-12-31


2020-12-31


245

Study Overview

Effects of Prehabilitation and Early Mobilization for Patients Undergoing Pancreas Surgery.

Open upper gastrointestinal surgery includes surgery in the upper abdomen such as ventricular, duodenal, pancreatic and biliary tract surgery. After upper abdominal surgery there is a risk of gastrointestinal and cardiopulmonary complications. There is currently insufficient knowledge about the effect of prehabilitation and extra early postoperative mobilization in upper pancreatic surgery. This study's aim is to evaluate the effect of prehabilitation and extra early mobilization. The study includes two substudies: 1. A prospective cohort of 75 patients undergoing pancreatic surgery after a prehabilitation program will be compared to 75 historical controls. Primary outcome is postoperative complications. 2. A randomized controlled trial based on 72 patients undergoing pancreatic studying the effect of extra early rehabilitation. The intervention group will be mobilized to bedside, standing or sitting in armchair <6 hours after surgery, ie 3-4 hours after arrival at the Postoperative Department (PIVA). The control group will be mobilized according to routine i.e. the morning after surgery. Primary outcome is PaO2.

N/A

  • Pancreas Cancer
  • OTHER: Prehabilitation
  • OTHER: Routine care
  • OTHER: Extra early mobilization
  • OTHER: Standard mobilization
  • FoU i VGR: 238701

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2018-02-23  

N/A  

2021-01-04  

2018-03-08  

N/A  

2021-01-05  

2018-03-15  

N/A  

2021-01  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
Prevention


Allocation:
Randomized


Interventional Model:
Parallel


Masking:
None


Arms and Interventions

Participant Group/ArmIntervention/Treatment
EXPERIMENTAL: Prospective cohort-prehabilitation

A prehabilitation program including advice about diet, increased physical activity and cessation of smoking and drinking alcohol.

OTHER: Prehabilitation

  • Prehabilitation concerning eating, smoking, drinking and physical activity
ACTIVE_COMPARATOR: Retrospective cohort

Routine care before the prehabilitation program was introduced

OTHER: Routine care

  • Preoperative information
EXPERIMENTAL: Extra early mobilization

Mobilization the day of surgery

OTHER: Extra early mobilization

  • Mobilization the day of surgery
ACTIVE_COMPARATOR: Traditional mobilization

Routine care with mobilization the day after surgery

OTHER: Standard mobilization

  • Mobilization the day after surgery
Primary Outcome MeasuresMeasure DescriptionTime Frame
Postoperative complicationsStandardized complications according to registerWhole study period from inclusion to one year after surgery
PaO2Arterial oxygen pressureThe day before surgery to the first day after surgery
Secondary Outcome MeasuresMeasure DescriptionTime Frame
EORTC-module genericQuality of life, EORTC-QLQ-C30 (Range 30-124) Low values correspond to high quality of lifeWhole study period from inclusion to one year after surgery
EORTC-module specific for pancreas cancerQuality of life QLQ-OG25 (Range 25- 100). Low values correspond to high quality of lifeWhole study period from inclusion to one year after surgery
EORTC-module for fatigueQuality of Life FA-R13 (range 12- 48). Low values correspond to high quality of lifeWhole study period from inclusion to one year after surgery
The Postoperative Recovery ProfileQuality of recovery according to Allvin et al. 19 statements which are rated on a four grade scale fron no problem to major problemWhole study period from inclusion to one year after surgery
Pancreatic cancer disease impact (PACADI) scoreDisease specific questionnaire, 8 statements rated on a visual analogue scale from 0 (no problem) to 10 (worst imaginable problem). Sum score are used for analysis (Range 0-80)Whole study period from inclusion to one year after surgery
SpirometryVital capacityFrom inclusion (during preoperative information 1-14 days before surgery) to the first postoperative day after the operation
Lenght of stayLength of stay at the hospitalFrom the day before surgery to discharge from the hospital (app 7-14 days)

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:

Accepts Healthy Volunteers:

    Inclusion Criteria:

  • Patients scheduled to undergo pancreatic surgery

  • Exclusion Criteria in substudy b:

  • Preoperative injury or disease making it impossible to perform the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Fagevik Olsen M, Becovic S, Dean E. Short-term effects of mobilization on oxygenation in patients after open surgery for pancreatic cancer: a randomized controlled trial. BMC Surg. 2021 Apr 7;21(1):185. doi: 10.1186/s12893-021-01187-2.